Search results
-
Dr Daniel Hodson
... to characterise how new therapeutic agents that are entering trials for lymphoma may exert some of their effect though changes in ...
-
Professor Tim Eisen
... AstraZeneca, where I am currently responsible for oncology trials from first in man to Phase II. ...
-
Dr Elena Provenzano
... My primary interest is the translational aspect of clinical trials particularly in the neoadjuvant setting. Current trials include ARTemis, PARTNER, PRIMETIME and Neo-RT clinical trials in ...
-
Dr Finian Leeper
... properties and a close relative obatoclax is in clinical trials for multiple cancers. (b) synthesis of thiamin diphosphate (TPP) ...
-
Dr Gaia Schiavon
... biomarkers and study designs in ‘window of opportunity’ trials - Identification of newer imaging criteria for response assessment to ... RECIST’s limitations - Pharmacodynamics in clinical trials, disease linkage data to guide indication selection and targeted patient ...
-
Dr George Follows
... post, and I am developing a translational science / clinical trials interest. I am the clinical lead for CLL and lymphoma in Cambridge, and chair the Haematology Clinical Trials team. I am a committee member of the Cambridge Clinical Cancer Trials ...
-
Professor Grant Stewart
... a focus on developing and promoting surgery related clinical trials and translational research. Grant has a specific interest in optimising ... Stewart has developed a range of interlinked clinical trials and translational research which are all underpinned by clinical ...
-
Dr Helen Morris
... and collaborated on a number of randomised controlled trials and other well-designed studies in the field of cancer and genetics in a ...
-
Dr Helen Hatcher
... lead investigator in several multicentre and international trials. ...
-
Dr Kelly Holmes
... setting up and co-ordinating the work for clinical research trials with the aim of developing novel imaging techniques in patients with ...